|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 413/14 | |||
| C07D 401/10 | |||
| C07D 401/12 | |||
| C07D 403/10 | |||
| C07D 403/14 | |||
| C07D 417/14 | |||
| C07D 471/04 | |||
| A61P 3/10 | |||
| A61P 9/00 | |||
| A61P 35/00 | |||
| A61P 29/00 | |||
| A61K 31/4725 | |||
| A61K 31/455 | |||
| A61K 31/496 |
| (11) | Number of the document | 3033336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14755117.0 |
| Date of filing the European patent application | 2014-08-14 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/052510 |
| Date | 2014-08-14 |
| (87) | Number | WO 2015/022546 |
| Date | 2015-02-19 |
| (30) | Number | Date | Country code |
| 201361865732 P | 2013-08-14 | US | |
| 201361865756 P | 2013-08-14 | US |
| (72) |
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
MEGHANI, Premji, GB
NOVAK, Andrew Richard, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Porton Down, Salisbury, SP4 0JQ,
GB
|
| (54) | INHIBITORS OF PLASMA KALLIKREIN |
| INHIBITORS OF PLASMA KALLIKREIN |